-
U.S. Inflation Drop Paves Way For Federal Reserve Rate Cuts: Will Cannabis Stocks Benefit?
Friday, July 12, 2024 - 11:54am | 758The recent drop in U.S. inflation has sparked discussions about potential interest rate cuts by the U.S. Federal Reserve Bank. As inflation cools, investors are reconsidering their portfolios, with cannabis stocks emerging as a potential opportunity. Cooling Inflation Trends Inflation in the U...
-
Does Size Matter? These Two Small-Cap Cannabis Stocks Are Masters Of Cash Flow And Credit Management
Thursday, July 11, 2024 - 10:05pm | 831C21 Investments (OTC: CXXI) and Vext Science (OTC: VEXT) have demonstrated notable financial performance, particularly in cash flow and credit stability. This is significant given the challenges faced by many larger cannabis companies. Despite market caps of $29.98 million for Vext and $33.33...
-
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
Thursday, July 11, 2024 - 3:01pm | 860The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical questions about the future of the cannabis industry, especially if cannabis is federally legalized. The...
-
$4.3B In Soft Drinks: Carlsberg Acquires Britvic In Bold Move Amid Cannabis Market Growth
Monday, July 8, 2024 - 10:33am | 777Carlsberg's (CARL-B.CO) recent $4.3 billion acquisition of Britvic, known for Robinsons squash and J20, highlights a strategic pivot for the Danish brewer. The deal will create a new entity, Carlsberg Britvic, to enhance its footprint in the UK and Western Europe. Following a previously...
-
Canadian Vs. U.S. Cannabis Companies: Who Is Winning The Market Race To Weed Profits?
Tuesday, June 25, 2024 - 7:01pm | 659The financial landscapes of Canadian and U.S. cannabis operators showcase distinct paths in the quest for profitability, driven by varying market dynamics and regulatory environments. According to recent financial data from Beacon Securities, the analysis of key financial metrics such as EV/EBITDA...
-
Maryland, Ohio And Illinois Defy The Trend In M&A Activity: What Investors Can Learn
Tuesday, June 11, 2024 - 9:36pm | 905Despite an overall decline in mergers and acquisitions (M&A) across the cannabis industry, a few states are bucking the trend, showcasing growth and resilience. Recent data from Viridian Capital Advisors provides a comprehensive view of this dynamic sector, highlighting intriguing patterns for...
-
What Ohio Investors Can Learn From Maryland's Cannabis Market: Sector Analyst Keeps It Simple
Monday, June 10, 2024 - 7:20pm | 743As Maryland's cannabis market matures, it offers valuable insights for states like Ohio preparing to launch recreational sales. Pablo Zuanic of Zuanic & Associates highlights Maryland's stability, competitive landscape and market dynamics as a potential model for other states....
-
Marijuana Stock Set To Rise On Your Watchlist: Verano Holdings Targets EBITDA And Lower Debt
Friday, June 7, 2024 - 8:17am | 682Senior analyst Pablo Zuanic of Zuanic & Associates released an update on Verano Holdings (OTC: VRNOF), which is crucial for investors monitoring the cannabis sector. Verano's sales for 2023 are projected at $938.5 million, with a potential EBITDA recovery to $300.4 million by 2025....
-
Rumors Of Green Thumb And Boston Beer Merger: What Investors Need to Know, Analyst Breaks It Down
Thursday, June 6, 2024 - 4:02pm | 797Green Thumb Industries (OTC: GTBIF) has expressed interest in merging with Boston Beer (NYSE: SAM), according to a recent report by Pablo Zuanic of Zuanic & Associates. What strategic advantages does this merger offer? How will this impact the profitability of both companies? Could this merger...
-
Psychedelic-Assisted Therapy In Vermont, State-Run Model In New Hampshire And Medical Marijuana In Arkansas
Wednesday, June 5, 2024 - 3:00pm | 356Vermont Psychedelics And Harm Reduction Legislation Vermont Governor Phil Scott signed a bill to create a task force for psychedelic-assisted therapy. This group will review research on psilocybin and MDMA, advising on their therapeutic regulation. However, Scott vetoed a measure to establish a...
-
TILT Holdings' Cannabis Sales Steady Despite Supply Disruptions, Are Debt And Stock Dilution Posing Risks?
Thursday, May 23, 2024 - 7:10pm | 511Vape Hardware Business Impacted TILT Holdings' (OTC: TLLTF) first-quarter 2024 results reveal disruptions in the vape hardware segment, which accounts for 71% of the company's sales in 2023. Pablo Zuanic from Zuanic & Associates notes, "Disruptions on the supply side of the vape...
-
Who Is Buying Marijuana And Why? Market Data Provides Behavior, Profiles & Insights For Investors
Thursday, May 23, 2024 - 9:47am | 699A recent report by Numerator, a first-party consumer-sourced data company, offers in-depth insights into the behaviors and profiles of contemporary cannabis consumers. The study, which surveyed nearly 6,000 current and past users of THC and CBD highlights significant differences in consumer...
-
$581M In Deals: Top States Draw Major Cannabis Investments Despite Market Downturn
Tuesday, May 7, 2024 - 4:41pm | 699In the latest report from Viridian Capital Advisors, investment trends in the U.S. cannabis industry show a marked decrease, despite significant capital inflows in leading states such as California, New York and Massachusetts. Over the last twelve months (LTM) ending May 3, 2024, there has...
-
Credit Check: What Does DEA Rescheduling Mean For Cannabis Credit Ratings? Big Companies' Risk-Return Profiles
Friday, May 3, 2024 - 11:57am | 578The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations of multi-state operators (MSOs). According to Viridian Capital Advisors' latest weekly credit report, the MSO index surged by 25% immediately after the announcement,...
-
A $25.5M Opportunity: 23 Marijuana Brands Compete For New Jersey's Budding Pre-Roll Market
Thursday, May 2, 2024 - 9:27am | 458The New Jersey cannabis market, boasting a 23% increase in overall cannabis revenue in the last quarter of 2023, is witnessing substantial growth, particularly in the pre-roll segment. Despite challenges such as limited brand diversity, pre-roll sales specifically rose by 8%, reaching a total...